Home | Novapep

Novapep is developing its biparetide peptide which is anti-inflammatory and cytoprotective to treat sepsis and other acute indications

The Company

Novapep is a biotech company whose scientists invented the Biparetide agonist peptide structure, which mimics the cell-signalling mechanisms of Activated Protein C

Based on highly promising preclinical data for biperatide in sepsis Novapep is developing intravenous biparetide for the treatment of sepsis which is anti-inflammatory, cytoprotective and provides endothelial barrier protection

Novapep is developing its biparetide peptide which is anti-inflammatory and cytoprotective to treat sepsis and other acute indications

The Company

Sepsis Program